EquityZen Growth Technology Fund LLC - Series 1685
Raised
$937K
Investors
31
Min Invest
$10,008
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1685 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors LLC and Philip Haslett. The fund raised $937K from 31 investors with a $10K minimum investment under Rule 506(b) and Section 3(c)(1) exemptions. This is part of the EquityZen platform, which operates approximately 1,889 related EDGAR entities focused on pre-IPO secondary market access.
This pre-IPO fund follows the standard EquityZen platform template with 506(b)/3(c)(1) exemptions and a retail-accessible $10K minimum, consistent with the platform's democratized access model to private company equity. The 31-investor base and sub-$1M raise reflect typical single-company SPV economics in the secondary pre-IPO market.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
